Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Canada Research Chairs

Université de Montréal

$200,000.00

Cellular Signalling and Cancer Metastasis

FY 2022-23

Summary
Our work focuses on important protein families that control cellular signalling required for the cytoskeletal dynamics events that orchestrate cell migration and invasion. The are key biological processes at the root of cancer progression to metastasis. Our research program is divided into 3 areas.First, we are interested to gain the fundamental knowledge of the molecular networks and the molecular mechanisms that contribute to cytoskeletal dynamics. These research efforts are focused on the RAS-family of proteins, such as the RHO and ARF subfamilies, and rely on proximity labeling approaches to reveal their interactomes at high-throughput. Combined with powerful functional studies, these efforts have led to important discoveries of mechanisms controlling cytoskeletal dynamics and cell migration and invasion.Second, we study the normal biological functions of these molecules such that we can better understand how they contribute to cancer progression. We have found that a number of the proteins studied above regulate a basic biological process known as cell-cell fusion. This includes RHO-family proteins and their regulators, and a number of their accessory proteins. This is a central biological function allowing to the building blocks of our muscles, the myoblasts, to unite their cellular membranes to form multi-nucleated cells. Our efforts exploit molecular, cellular and in vivo approaches, and are currently centered on defining the precise cytoskeletal-drive mechanisms regulating cell fusion.Third, we have developed a broad approach to study the cellular and molecular processes that contribute to breast cancer metastasis. This includes functional studies in breast cancer cells and the development of mouse models that can answer the contributions of our specific new genes to metastasis. We study the roles of kinases and cytoskeletal regulators. Our goal is to attempt to understand breast cancer cells behavior as they navigate through the metastatic cascade. This includes when leaving the primary tumours and invading secondary organs, but also how they integrate and survive into the new foreign environment to form micro- or macro-metastases.Our work will contribute important new basic mechanistic information on the signalling networks that contribute to normal cell biology and to cancer metastasis. This knowledge is needed to develop the new and much needed innovative therapies aiming at limiting cancer spreading, a serious health threat.
Program
Canada Research Chairs
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
CRC-2021-00161
Name nom
Côté, Jean-François
Department département
Cytoskeletal Organization and Cell Migration
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2021
Award amount
200000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Installment
inst:1;4
Partie
4
Nb partie
4
Application title
Cellular Signalling and Cancer Metastasis
Application summary
Our work focuses on important protein families that control cellular signalling required for the cytoskeletal dynamics events that orchestrate cell migration and invasion. The are key biological processes at the root of cancer progression to metastasis. Our research program is divided into 3 areas.First, we are interested to gain the fundamental knowledge of the molecular networks and the molecular mechanisms that contribute to cytoskeletal dynamics. These research efforts are focused on the RAS-family of proteins, such as the RHO and ARF subfamilies, and rely on proximity labeling approaches to reveal their interactomes at high-throughput. Combined with powerful functional studies, these efforts have led to important discoveries of mechanisms controlling cytoskeletal dynamics and cell migration and invasion.Second, we study the normal biological functions of these molecules such that we can better understand how they contribute to cancer progression. We have found that a number of the proteins studied above regulate a basic biological process known as cell-cell fusion. This includes RHO-family proteins and their regulators, and a number of their accessory proteins. This is a central biological function allowing to the building blocks of our muscles, the myoblasts, to unite their cellular membranes to form multi-nucleated cells. Our efforts exploit molecular, cellular and in vivo approaches, and are currently centered on defining the precise cytoskeletal-drive mechanisms regulating cell fusion.Third, we have developed a broad approach to study the cellular and molecular processes that contribute to breast cancer metastasis. This includes functional studies in breast cancer cells and the development of mouse models that can answer the contributions of our specific new genes to metastasis. We study the roles of kinases and cytoskeletal regulators. Our goal is to attempt to understand breast cancer cells behavior as they navigate through the metastatic cascade. This includes when leaving the primary tumours and invading secondary organs, but also how they integrate and survive into the new foreign environment to form micro- or macro-metastases.Our work will contribute important new basic mechanistic information on the signalling networks that contribute to normal cell biology and to cancer metastasis. This knowledge is needed to develop the new and much needed innovative therapies aiming at limiting cancer spreading, a serious health threat.
Université de Montréal - $200,000 Grant (2022-23) | Canada Spends